Nathan Carpenter

Commercial and Business Litigation

• A global biopharmaceutical company in litigation connected to a merger transaction with a contingent value right agreement concerning applications before the U.S. Food and Drug Administration;
• Defense against applications for a preliminary injunction and temporary restraining order filed to prevent a nearly $500 million merger of a special purpose acquisition company with a health food company;
• A global supplier of specialty ingredients in derivative litigation alleging breaches of fiduciary duty related to its debt practices and corporate governance;
• Securities litigation claims that an international clean energy company made misrepresentations and omissions concerning accounting practices and financial disclosures;
• Securities litigation claims that an international food and personal-care company made misrepresentations and omissions concerning consumer demand and inventory levels;
• State court litigation and mediation concerning allegations of fraud, misrepresentation, and breach of contract following an energy company’s purchase of a power plant; and
• An international bank in connection with allegations that it provided material support and/or aided and abetted a terrorist organization in commissioning, authorizing, or planning an act of international terrorism.

White Collar Investigations

• An international technology company’s internal investigation following a cyber-attack and response to investigations conducted by the United States Department of Justice, the Securities and Exchange Commission, and the New York Attorney General’s Office, as well as other federal and state agencies;
• An infrastructure software company’s response to investigations conducted by various state attorney general’s offices and related litigation following a cyber-attack;
• A privacy and security software provider’s internal investigation following a cyber-attack;
• An Audit Committee of the Board of Directors of an international technology firm in the investigation into potential revenue recognition matters at the Company’s foreign subsidiary; and
• An international pharmaceutical company's investigation into whistleblower allegations related to the Foreign Corrupt Practices Act.

Intellectual Property Litigation

• International arbitration concerning trade secret misappropriation claims arising out of joint development agreements involving an international corporation's exploration of renewable resources;
• An international engineering company in a complex patent litigation involving cross-claims against a competitor involving technology related to hard disk drive suspension assemblies; and
• A clinical stage biotechnology company concerning claims of trade secret misappropriation related to the development of an antibody for treatment of a rare and often fatal disease.